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  Foot & ANKLe
The UK Foot and Ankle COVID-19 
National (FAlCoN) audit
Rate Of COVID-19 InfeCtIOn anD 30- Day MORtaLIty In fOOt anD 
ankLe suRgeRy In the uk DuRIng the COVID-19 PanDeMIC
Aims
The primary objective was to determine the incidence of COVID-19 infection and 30- day 
mortality in patients undergoing foot and ankle surgery during the global pandemic. Sec-
ondary objectives were to determine if there was a change in infection and complication 
profile with changes introduced in practice.
Methods
This UK- based multicentre retrospective national audit studied foot and ankle patients who 
underwent surgery between 13 January and 31 July 2020, examining time periods pre- UK 
national lockdown, during lockdown (23 March to 11 May 2020), and post- lockdown. All 
adult patients undergoing foot and ankle surgery in an operating theatre during the study 
period were included. A total of 43 centres in England, Scotland, Wales, and Northern Ire-
land participated. Variables recorded included demographic data, surgical data, comorbidi-
ty data, COVID-19 and mortality rates, complications, and infection rates.
Results
A total of 6,644 patients were included. Of the operated patients, 0.52% (n = 35) contracted 
COVID-19. The overall all- cause 30- day mortality rate was 0.41%, however in patients who 
contracted COVID-19, the mortality rate was 25.71% (n = 9); this was significantly higher for 
patients undergoing diabetic foot surgery (75%, n = 3 deaths). Matching for age, American 
Society of Anesthesiologists (ASA) grade, and comorbidities, the odds ratio of mortality with 
COVID-19 infection was 11.71 (95% confidence interval 1.55 to 88.74; p = 0.017). There were 
no differences in surgical complications or infection rates prior to or after lockdown, and 
among patients with and without COVID-19 infection. After lockdown the COVID-19 infec-
tion rate was 0.15% and no patient died of COVID-19.
Conclusion
COVID-19 infection was rare in foot and ankle patients even at the peak of lockdown. Howev-
er, there was a significant mortality rate in those who contracted COVID-19. Overall surgical 
complications and postoperative infection rates remained unchanged during the period of 
this audit. Patients and treating medical personnel should be aware of the risks to enable 
informed decisions.
Cite this article: Bone Jt Open 2021;2-4:216–226.
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Introduction
since December 2019, the global COVID-19 
pandemic has had a devastating effect 
on healthcare systems worldwide, with 
38,002,699 confirmed cases and 1,083,234 
deaths as of 14 October 2020.1 In the uk, nhs 
england declared a Level-4 national incident 
on 30 January 2020; as hospital resources 
became overwhelmed, nhs england 
requested that nhs hospitals reduce all elec-
tive activity to the point of postponing all 
nonurgent elective procedures for a period 
of at least three months from 15 april 2020. 
globally, Phillips et al2 found 11 reports of 
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table I. summary of continuous variables of whole dataset.
Continuous variable Mean SD Range
age, yrs 51.90 17.96 16 to 99
Length of surgery, mins 84.50 55.52 0 to 620
Length of stay, days 3.79 8.91 0 to 165
number of operations patient had 1.04 0.24 1 to 7
time from listing/injury to surgery, days 56.81 97.34 0 to 983
total number of comorbidities 0.95 1.16 0 to 10
time from surgery to COVID diagnosis, days 10.38 8.99 -7 to 28
sD, standard deviation.
Fig. 1
flow diagram displaying data cleansing of submitted data, with different levels of case exclusion.
either selective or complete postponement of elective 
activity issued by orthopaedic governing bodies. On 23 
March 2020, the uk government announced a national 
lockdown with the publication of guidance on “staying 
at home and away from others (social distancing)”.3 
surgical governing bodies also produced guidance 
on the rationing of services due to scarcity of hospital 
resources.4
Regarding foot and ankle surgery in the uk, guidance 
was only issued specifically pertaining to the treatment 
of urgent orthopaedic conditions and trauma, aiming 
to maximize resource capacity, ensure patient and staff 
safety, and enable triage and contraction of services as 
physical and personnel resources diminished.4 further 
guidance on the prioritization of cases in trauma and 
orthopaedics was issued by the federation of surgical 
speciality association, however only cases with removal 
of metal work across a joint and removal of intra- articular 
loose bodies were given elective ‘high priority’ status.5 
the impact of COVID-19 and the risks it posed to health-
care personnel and patients who were to undergo surgery 
is still, at the time of writing, relatively unknown. the 
COVIDsurg collaborative published a multicentre obser-
vation study showing the significantly increased risks 
of mortality and morbidity in patients with COVID-19 
infection at or around the time of surgical intervention. 
however, the risk of contracting the infection during or 
around the surgery was not assessed.6 attempts have 
been made to estimate the risks of undergoing elective 
orthopaedic surgery for asymptomatic patients with a 
negative saRs- CoV-2 test, however this remains theo-
retical.7 a recent national cohort study on upper limb 
surgery in the uk found that in 1,093 surgically treated 
patients in april 2020, the risk of complication due to 
COVID-19 infection was 0.18%.8
the primary objectives of this study were to deter-
mine the percentage of patients receiving foot and ankle 
surgery in the uk during the audit period who were posi-
tive for COVID-19, and to audit their 30- day mortality 
rate. secondary outcomes included comparing early 
complications of foot and ankle surgery in pre- and post- 
COVID-19 changes of practice.
Methods
Study design. this was a retrospective national audit of 
foot and ankle procedures, which had occurred in 43 uk 
centres (supplementary Material) between 13 January 
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negative 1,413 687 1,481 3,581 92 27 84 203 2,476 30 319 2,825
Positive 12 13 3 28 1 3 0 4 3 0 0 3
total 1,425 700 1,484 3,609 93 30 84 207 2,479 30 319 2,828
Percentage 0.84 1.86 0.20 0.78 1.08 10.00 0.00 1.93 0.12 0.00 0.00 0.11








p- valueNegative Positive Alive Dead
number 105 35 number 76 27
Means (continuous) Means (continuous)
number of 
operations
1.04 1.03 0.794 number of 
operations
1.01 1.07 0.108
age 64.7 64.46 0.949 age 66.82 67.44 0.868
LOs 8.01 14.06 0.037 LOs 7.35 16.38 0.001
Operating time 78.89 107.08 0.025 Operating time 85.9 99.36 0.337
Comorbidities 2.23 2.2 0.941 Comorbidities 2.59 2.63 0.926
Categorical (significance) Categorical (significance)
urgency higher COVID-19 rate in patients who had 
urgent surgery
0.001 COVID-19- positive higher COVID-19 rate in patients who died < 0.001
Complications higher COVID-19 rate in patients who had 
non- surgical complications
< 0.001 nCePOD higher mortality in those who had urgent 
surgery
0.022
Mortality higher mortality rate in patients with 
COVID-19
< 0.001 Complications higher non- surgical complications in patients 
who died
0.008
trauma / elective high COVID-19 rates in trauma patients 
and diabetic patients





highest COVID-19 rates during lockdown < 0.001   
LOs, length of stay; nCePOD, national Confidentiality enquiry into postoperative deaths.
2020 and 31 July 2020. all patients who had under-
gone a foot and ankle surgical procedure were includ-
ed in this study. Data was collected and anonymized by 
each participating nhs trust site and transferred securely 
to university hospitals of Leicester nhs trust (primary 
trust). Data collected were on comorbidities, physiolog-
ical state, treatment/operation, and outcome. Data gov-
ernance was dictated by european general data protec-
tion regulations. the study was approved and registered 
as a clinical audit at the lead centre (Ref no. 10795). to 
participate, each local project lead needed to confirm lo-
cal audit approval.
In each unit, patients were identified retrospectively 
if they had undergone foot and ankle surgery in an 
operating theatre. Patients were categorized into those 
who had COVID-19 at the time of surgery (identified as 
patients who had test- proven or clinically diagnosed 
COVID-19 infection up to seven days before surgery), 
patients who had developed COVID-19 after their 
surgery (identified as patients in whom COVID-19 was 
first suspected during their index admission or within 
the 30 days following surgery), or patients who did not 
contract COVID-19 or contracted COVID-19 outside of 
the period described above. the thresholds for these 
different cohorts are in keeping with other COVID-19 
surgical studies.6
the inclusion criteria for this audit were all patients 
undergoing any foot and ankle surgery in an operating 
theatre by an orthopaedic surgeon. each theatre atten-
dance was recorded as a separate event, and any multiple 
events required secondary analysis due to the theoret-
ical increase in risk of COVID-19 infection. Diagnosis of 
COVID-19 was based on either a positive saRs- CoV-2 lab 
test or Ct chest scan or a clinical diagnosis (no COVID-19 
lab test or Ct chest performed) as per study protocols of 
other COVID-19 surgical studies.6
site investigators were provided with a range of 
written materials, including study protocols, data collec-
tion sheets, audit enrolment advice, and data protection 
agreements. In addition, investigators were invited to 
contact the national project leads for the purpose of trou-
bleshooting site- specific recruitment issues and shared 
learning. these learning experiences were then shared 
across sites via electronic communication and displayed 
on the British Orthopaedic foot and ankle society study 
specific website pages.
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Data collection. Laboratory testing for COVID-19 infec-
tion was based on saRs- Cov-2 viral Rna detection by 
quantitative reverse transcription- polymerase chain reac-
tion. sampling, including nasal swabs or bronchoalveo-
lar lavage, and analyses were done according to individu-
al hospital protocols. all work was done in nhs hospitals 
in the uk, where the procedures for COVID-19 identifi-
cation were standardized as per government guidelines. 
Due to the limited testing availability in the early part 
of the COVID-19 outbreak, patients were also included 
based on either clinical or radiological findings. Clinical 
diagnosis consistent with COVID-19 infection was made 
by a senior physician and based on clinical presentation 
of symptoms highly indicative of COVID-19 infection, in-
cluding a new continuous cough, fever (37.8°C), or an 
inability to smell or taste.9 Radiological diagnosis was 
based on thorax Ct, in keeping with locally implemented 
protocols. all patients included initially based on clinical 
or radiological criteria, who subsequently had laboratory 
testing for saRs- CoV-2 infection and returned a negative 
result, were excluded from the study.
anonymized data were collected locally on encrypted 
spreadsheets before being uploaded to the Research 
electronic Data Capture web application (ReDCap, usa). 
Data were collected from 13 January 2020 to 31 July 
2020, allowing final 30- day mortality data to be collected 
on 30 august 2020. time periods were divided according 
to national guidance on the uk national lockdown (23 
March 2020) and easing of the lockdown (11 May 2020).3
We collected patient demographic details such as sex, 
age, ethnicity,10 and american society of anesthesiolo-
gists (asa)11 physical status classification. the primary 
outcome for COVID-19 diagnosis was recorded with the 
timing of COVID-19 diagnosis as either preoperative or 
postoperative. the method of COVID-19 diagnosis was 
entered as categorical data based on clinical or laboratory- 
based diagnoses. treatment of COVID-19 and any related 
complications were entered as categorical data.
surgery- related variables were included. the foot and 
ankle diagnosis was recorded as categorical data. the 
diagnosis was classified based on limited variables based 
broadly on trauma, diabetic, and elective practice. this 
was further divided by anatomical region and procedure. 
Operative variables included urgency (elective or emer-
gency surgery), primary procedure completed (classified 
into manipulation under anaesthetic/plaster, percuta-
neous surgery, external fixation, open surgery, injection, 
and arthroscopic procedure as categorical data), and 
anaesthesia used (local, regional, general, or combina-
tion). Other surgical data included length of stay (days, 
COVID-19- positive length of stay recorded to point of 
diagnosis), urgency of surgery, and length of operation 
(recorded in minutes, including anaesthetic time). Dates 
recorded included date of injury for trauma and date of 
listing for elective, date of admission, date of surgery, 
and date of discharge. emergency surgery was defined 
as procedures classified by the national Confidential 
enquiry into Patient Outcome and Death (nCePOD) as 
immediate, urgent, or expedited.12 Comorbidities were 
entered as binary data into columns for current smoker, 
asthma/chronic obstructive pulmonary disease, cancer, 
chronic kidney disease, cardiac disease, dementia, 
diabetes mellitus, hypertension, peripheral vascular 
disease, and stroke. It was possible for other comorbid-
ities to be entered by free text.
the secondary outcomes included surgery- related 
infection (recorded as either superficial or deep), compli-
cations as binary data (surgery- related and non- surgery- 
related), and the ability to free text. Mortality was entered 
as categorical data (alive, died on table, died on day 0 to 
7, and died on day 8 to 30 with the day of surgery defined 
as day 0). Before locking of the dataset for analysis, the 
senior local principal investigator for each hospital was 
asked to confirm data completeness and that all eligible 
patients had been entered into the database.
Statistical analysis. the study was completed according 
to strengthening the Reporting of Observational studies 
in epidemiology (stROBe) guidelines for observational 
studies.13 Continuous variables were tested for normal-
ity distribution, and presented as means and 95% con-
fidence intervals (95% CIs). Whereas categorical and 
qualitative variables are expressed as numbers and per-
centages. theindependent- samples t- test and analysis of 
variance (anOVa) were used for continuous variables if 
the criteria for normality and equality of variances were 
fulfilled. alternatively, the Mann- Whitney u test was per-
formed. Categorical variables were analyzed using the 
chi- squared test for sample sets greater than 5, otherwise 
the fisher’s exact test was used. Missing data were in-
cluded in flowcharts and descriptive analyses, allowing 
denominators to remain consistent in calculations.
normality tests were completed for all continuous vari-
ables as illustrated in supplementary Material 1. the vast 
majority of continuous variables were normally distrib-
uted regardless of subset breakdown with the exception 
of age, length of stay, and duration of surgery for COVID-
19- positive patients and for overall mortality. a summary 
of overall continuous variables is illustrated in table I.
In order to eliminate confounding demographic vari-
ables, propensity matching was performed with a 1:3 
ratio for patients with COVID-19 infection and patients 
who died. the demographic variables to match with 
were chosen based on those which differed significantly 
between groups via anOVa. the ratio of 1:3 was chosen 
so as to not discard usable data and matching was done 
with a random seed.
a binomial or multinomial logistic regression anal-
ysis was performed including all variables with p- values 
of < 0.15 from initial univariate analysis. for COVID-19 
and mortality groups the regression was performed on 
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table IV. summary of 30- day mortality cross- tabulation by surgical type and time period.















survived beyond 30 
days
1,402 678 1,479 3,559 91 27 82 200 2,475 30 318 2,823 6,582
Died within 30 days 7 6 0 13 1 0 2 3 1 0 1 2 18
CoVID-19- positive
survived beyond 30 
days
8 12 3 23 0 1 0 1 2 0 0 2 26
Died within 30 days 4 1 0 5 1 2 0 3 1 0 0 1 9









33.33 7.69 0.00 17.86 100 66.67 0.00 75 33.33 0.00 0.00 33.33 25.71
Percentage mortality 
all- cause
0.77 1.00 0.00 0.50 2.15 6.67 2.38 2.90 0.08 0.00 0.31 0.11 0.41
matched data. the results were reported as odds ratios 
(ORs) with 95% CIs. In general, a two- sided p < 0.05 was 
considered to be statistically significant. the primary 
adjusted model included preoperative variables to iden-
tify predictors of 30- day mortality. all data were assessed 
using sPss v. 26.0 (IBM, usa).
Role of the funding source. this study was a collaborative 
effort of the Outcomes committee and scientific com-
mittee of the British Orthopaedic foot and ankle society 
who were involved in study design, data analysis, data 
interpretation, and writing of the report. the funders of 
the study had no role in the aforementioned aspects of 
the study. the corresponding author and analysis group 
had full access to all the data in the study and the cor-
responding author and the writing committee had final 
responsibility for the decision to submit for publication.
Results
a total of 43 uk centres participated in the audit and 
submitted cases as per the audit protocol. the total 
number of submitted episodes of surgically treated 
foot and ankle pathology was 7,413. as per the flow 
diagram in figure 1, following exclusion of cases as per 
audit protocol, 6,644 cases were left for further analysis. 
there was a 92.14% completion rate of all continuous 
and categorical data, with length of surgery being the 
most common missing continuous variable and ethnicity 
being the most common categorical missing variable. 
the breakdown of variable completion is documented 
in supplementary Material 2. all COVID-19- specific cases 
had 97% completion of continuous data and 100% 
completion rate of categorical data.
Cases positive for symptomatic CoVID-19. a total of 
35 patients were confirmed positive for symptomatic 
COVID-19. all but one case was diagnosed subsequent to 
the surgical procedure. the one patient who developed 
COVID-19 preoperatively was a 32- year- old trauma pa-
tient with asa grade 2 (hypertension and asthma). they 
sustained their injury after their COVID-19 diagnosis and 
underwent urgent open fixation of an ankle fracture un-
der regional anaesthesia. they suffered only minor res-
piratory complications, requiring ward- based oxygen 
during their admission. they recovered uneventfully and 
were discharged five days postoperatively.
the categorization of cases into both surgical type 
(trauma surgery, diabetic surgery, and elective surgery) 
and time period is illustrated in table II. More COVID-19- 
positive cases were seen in trauma and diabetic patients 
(p < 0.001, anOVa) with the highest percentage being 
in diabetic patients during lockdown (10%, 3/30). Vari-
ables which correlated significantly with being positive 
for COVID-19 included an increase in age (COVID-19- 
negative mean 51.83 years (sD 17.92) vs COVID-19- 
positive mean 64.46 years (sD 20.38); p < 0.001), length 
of stay (COVID-19- negative mean 3.74 days (sD 8.86) vs 
COVID-19- positive mean 14.06 (sD 13.18) p < 0.001), 
increase in urgency on nCePOD (p < 0.001), higher asa 
grade (p < 0.001), and presence of comorbidities (p < 
0.001, all independent- samples t- test). using propensity 
matching controlling for age, comorbidities, and asa 
grade there was a significantly lower risk of COVID-19 in 
the elective group and in the post- lockdown time period. 
these data are summarized in table  III. there were 237 
patients who underwent multiple surgical procedures. 
having multiple surgical procedures did not increase the 
incidence of COVID-19 in this cohort.
Mortality. In the entire cohort there was a total of 27 
deaths, including nine deaths of COVID-19- positive pa-
tients. therefore, the all- cause mortality rate in foot and 
ankle surgery in this cohort was 0.41%. excluding the 
COVID-19 cases from analysis, the all- cause mortality 
reduces to 0.27%. the further breakdown of numbers 
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Fig. 2
graphical representation of mortality rates for patients diagnosed with 
COVID-19, categorized into time periods and by case type.
table V. Logistic regression results of significant predictors for propensity 
matched data for patients with COVID-19 diagnosis (35 positive patients 
vs 105 negative patients). Propensity matching was performed for age, 
american society of anesthesiologists grade, and comorbidities. the only 
significant variables predicted by COVID-19- positive status were morbidity 










Model significance p < 0.001*
Pseudo R- squared 0.426
Predictor of COVID-19- negative 
status
98.1%
Predictor of COVID-19- positive 
status
37.5%
Overall COVID-19 model prediction 83.7%
Variables with significant 
correlation
p- value oR 95% CI
Mortality 0.005* 39.85 2.97 to 534.22
Complications (overall) 0.065 n/a n/a
non- surgical complications vs no 
complications
0.028* 14.86 1.34 to 164.23
CI, confidence interval; n/a, not applicable; nCeOPD, national 
Confidentiality enquiry into postoperative deaths; OR, odds ratio.
table VI. Logistic regression results of significant predictors for propensity 
matched data for patients who died within 30 days of surgery (27 mortality 
patients vs 76 non- mortality patients). Propensity matching was performed 
for age, american society of anesthesiologists grade, and comorbidities. 
the only significant variables predicting mortality were presence of 









Model significance p < 0.001*
Pseudo R- squared 0.481
Predictor of ‘alive’ status 94.7%
Predictor of mortality status 50.0%
Overall Mortality Model Prediction 83.2%
Variables with significant 
correlation
p- value oR 95% CI
COVID-19- positive 0.017* 11.71 1.55 to 88.74
nCePOD (overall) 0.098 n/a n/a
nCePOD ‘urgent’ vs nCePOD 
‘elective’
0.034* 39.31 1.32 to 1,175.24
CI, confidence interval; n/a, not applicable; nCePOD, national 
Confidentiality enquiry into postoperative deaths; OR, odds ratio.
depending on surgical type and time period is illustrated 
in table IV. the highest rate of 30- day all- cause mortali-
ty, excluding COVID-19 cases, was witnessed in diabetic 
surgery post- lockdown (2.38%). the highest rate of both 
30- day all- cause mortality was witnessed in diabetic foot 
and ankle surgery during lockdown (6.67%) and the 
highest rate of mortality associated with COVID-19 was 
witnessed in diabetic foot and ankle surgery group pre- 
lockdown; there was only one patient in this subgroup, 
and this patient died.
On analysis of only the COVID-19- positive cases, 
the overall mortality rate was 25.71%. the factors that 
correlated with COVID-19 cases on regression analysis 
were also found to correlate with mortality. there were 
significant differences between COVID-19- negative- 
related and COVID-19- positive- related mortality rates 
pre- lockdown (p < 0.001) and during lockdown (p = 
0.001), however post- lockdown there was no difference. 
there has not been a COVID-19- related death in the post- 
lockdown time period (figure 2).
On propensity matched regression analysis (1:3 
matching), the strongest independent risk for mortality 
was a positive diagnosis of COVID-19 (OR 11.7, 95% CI 
1.55 to 88.74; p = 0.017). urgency of surgery was the 
next major factor in increasing all- cause 30- day mortality, 
with immediate surgery having an OR of 39.31 (95% CI 
1.31 to 1,175.23) compared to elective surgery, however 
urgency was not significant overall. there was a reduced 
risk of death in elective surgery and an increased risk 
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table VII. summary of complication cross- tabulation by surgical type and time period.














none 1,286 641 1,359 3,286 71 17 58 146 2,340 27 301 2,668 6,100
surgical 101 43 96 240 13 7 11 31 116 2 14 132 403
non- surgical 34 13 27 74 9 6 15 30 23 1 3 27 131
total 1,421 697 1,482 3,600 93 30 84 207 2,479 30 318 2,827 6,634
Percentage surgical 7.11 6.17 6.48 6.67 13.98 23.33 13.10 14.98 4.68 6.67 4.40 4.67 6.07
Percentage non- 
surgical
2.39 1.87 1.82 2.06 9.68 20.00 17.86 14.49 0.93 3.33 0.94 0.96 1.97
table VIII. Regression analysis on the overall risk of surgical related 
complications.
Surgical complications Significance oR 95% CI
Factor
Length of stay 0.18 1.014 1.002 to 1.026
Dementia 0.023 2.828 1.152 to 6.94
nCePOD 0.001 7.473 2.376 to 23.505
Superficial infections
time from injury to 
surgery
0.006 1.002 1.001 to 1.004
Length of procedure 0.022 1.003 1 to 1.006
smoker 0.004 1.809 1.202 to 2.72
Diabetes 0.035 1.853 1.045 to 3.288
Deep infections
Length of stay 0.004 1.021 1.007 to 1.036
Non- surgical 
complications
COVID-19- positive 0.009 5.218 1.523 to 17.876
Mortality 0.013 5.193 1.409 to 19.178
Length of stay < 0.001 1.029 1.018 to 1.041
Infection < 0.001 0.068 0.028 to 0.162
appendix 1 - normality tests of continuous variables.
CI, confidence interval; nCePOD, national Confidentiality enquiry into 
postoperative deaths; OR, odds ratio.
of death in patients with non- surgical complications, 
but this was not statistically significant. the analysis for 
mortality can be seen in tables IV to VI.
Complications. Complications were recorded initially as 
surgical and non- surgical related. across all surgical pro-
cedures there was a 6.07% incidence (n = 403) of surgical 
and 2.05% incidence (n = 136) of non- surgical compli-
cations. the highest incidence of both surgical and non- 
surgical related complications occurred in the diabetic 
foot and ankle surgery group (n = 31, 14.98% and n = 30, 
14.49% respectively). the breakdown of complications 
by surgical type is illustrated in table VII.
Regression analysis (table  VIII) on the overall risk of 
surgical related complications showed the highest inde-
pendent risk factor was the urgency of surgery, with 
immediate surgery having an OR of 7.47 (95% CI 2.37 
to 23.51; p = 0.001) increased risk of complications 
compared to elective surgery. no other measured surgery 
related factors showed a significant increase in risk of 
overall non- surgical complications. Of the comorbidities 
recorded, dementia had a small increase in risk of devel-
oping surgical complications.
specifically regarding surgical related infections, small 
increases in risk for superficial infections were seen in 
longer operations, smokers, diagnosis of diabetes, longer 
surgery procedure time, and increased time from injury 
to surgery. for deep infections there was an increased risk 
with length of stay, however this could be an effect rather 
than a cause.
Relating to COVID-19- positive cases, respiratory 
complications were reported in 51.43% of the 35 cases, 
with minor respiratory complications in 17.14% (n = 6) 
and major respiratory complications in 34.29% (n = 12). 
Diabetic surgery had a higher rate of respiratory compli-
cations. Renal complications were reported in 17.14% of 
COVID-19- positive cases (n = 6), again more commonly in 
diabetic surgery compared to trauma or elective surgery 
(25.00%, 17.86%, and 0% respectively), as summarized 
in figure 3.
Discussion
the primary objective of this national audit was to 
determine the percentage of patients receiving foot and 
ankle surgery in the uk during the audit period who 
were positive for COVID-19, and to audit their 30- day 
mortality rate. although the audit did not include 
all centres in the country, the percentage of patients 
receiving foot and ankle surgery who had a positive 
diagnosis for COVID-19 in the perioperative period was 
determined to be 0.52% (35 COVID-19- positive cases 
in 6,644 patients). a number of authors have discussed 
the concept of establishing non- COVID-19 Care zones 
including standalone hospitals, separate units on site, 
or specialized wards to facilitate patient admission and 
discharge.14 Before lockdown there were three COVID-
19- positive patients in elective foot and ankle surgery, 
one of whom died (table II).
the total all- cause 30- day mortality rate in our study 
was found to be 0.41%, decreasing to 0.27% if COVID-19 
positive patients were excluded. In patients positive 
for COVID-19, there was a 25.71% chance of mortality 
(table  IV). this rate is not dissimilar to rates reported 
in hip fracture patients who underwent surgery for 
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Fig. 3
graphical representation of type of treatment received by patients with COVID-19 and the related complications they experienced.
proximal femoral fractures, with a spanish multicentre 
observational study on 136 proximal femoral fractures 
reporting a mortality rate for 23 COVID-19- positive 
patients to be 30.4% (7/23) at a mean follow- up of 14 
days.15 a large multicentre review in the uk, comparing 
340 COVID-19- negative patients with 82 COVID-19- 
positive patients undergoing surgery for hip fractures, 
also reported a substantial increase in mortality rates 
(30.5% (25/82) vs 10.3% (35/340).16 a national cohort 
study on upper limb surgery in the uk in april 2020 
found the overall 30- day mortality was 0.09% (one 
pre- existing COVID-19 pneumonia) and the mortality 
of day case surgery was zero.8 they also report that 
there were 19 confirmed cases of COVID-19 in their 
cohort (1.7%), but when only including the confirmed 
cases the percentage of mortality in COVID-19- positive 
patients was 5.25%. the COVIDsurg collaborative 
reported a 30- day mortality of 23.8% in 1,128 COVID-
19- positive patients undergoing surgery of any kind.6 
therefore, the current study highlights the importance 
to counsel patients of the increased risk of mortality 
when undergoing foot and ankle surgery during the 
COVID-19 pandemic.
Our audit may not be comparable to the previous 
studies in other surgical specialties, due to the larger 
numbers in our cohort and the longer period of time it 
analyzed. for example, the upper limb study by Dean 
et al8 only analyzed the reported uk COVID-19 peak in 
april, however 45.71% (16/35) of our positive cases and 
66.67% (6/9) of our COVID-19- related deaths occurred 
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prior to their date of analysis. the mortality rate across 
the three time periods has significantly reduced, with 
no cases of deaths related to COVID-19 reported after 
lockdown. similarly, the studies relating to hip frac-
tures and all surgery reported on the early stages of the 
pandemic.6,15,16 there are many factors contributing to 
the relative reduction over time of the mortality rate in 
our study, such as reducing prevalence in the popula-
tion, triaging of surgical practice,4 and an improvement 
in the care of the respiratory sequalae of the COVID-19 
infection.17 In our cohort, all but one patient developed 
COVID-19 post- surgery. the COVIDsurg collaborative 
recently published evidence that waiting longer than 
four weeks post- positive test for COVID-19 was protec-
tive of both pulmonary complications and mortality.18 
In our series, there was only one patient who under-
went surgery following a positive COVID-19 diagnosis. 
this was classed as urgent ankle trauma surgery under 
regional anaesthesia and did not develop any major 
pulmonary or renal complications.
Our audit also established that there was no differ-
ence between surgical and non- surgical complications 
of foot and ankle surgery between the time periods 
of pre- lockdown, lockdown, and post- lockdown 
(table VII). there was, however, a significant difference 
in rate of complications between surgical types, with 
diabetic foot and ankle surgery carrying the highest 
risk, followed by trauma surgery, and with elective 
surgery carrying the lowest risk. therefore, any system 
changes that have occurred during or post- lockdown 
do not appear to have increased the risk of complica-
tions in patients. smeeing et al19 reported an increased 
risk of wound complications in ankle fractures with 
increasing age, asa grade, and smoking. Our audit has 
shown these risk factors to be ubiquitous across all foot 
and ankle surgery regardless of relation to COVID-19 
infection. the main overall factor for the development 
of complications across the audit, however, was the 
urgency of surgery.
Diabetic surgery had the highest risk of respiratory 
and renal complications related to COVID-19, although 
diabetes as a comorbidity did not carry an increased 
risk across the entire audit population. this may repre-
sent the difference of ‘complicated’ diabetes or decom-
pensated diabetic disease, as termed by gougoulias et 
al,20 where the act of undergoing diabetic surgery (i.e. 
surgery to the foot and ankle due to pathology mani-
fested by decompensated diabetes) is evidence of the 
presence of chronic poor glycaemic control. a number 
of studies have reported changing practices globally 
in an effort to reduce the exposure of diabetic patients 
with related foot pathology to COVID-19.21,22 however, 
our audit has shown the significant COVID-19- related 
risk (i.e. respiratory complications and death) diabetic 
surgery incurs in the time of the COVID-19 pandemic 
and therefore all effort needs to be made in prevention 
of foot and ankle complications that may result in the 
need for surgery.
Our study has limitations. firstly, this was a retro-
spective audit of observational data. although it is the 
largest audit of its kind in foot and ankle surgery, it does 
not fully represent the uk practice. this study included 
all patients undergoing foot and ankle surgery in 
an operating theatre, however during the lockdown 
period a number of patients may have had interven-
tions outside of an operating theatre or may have been 
treated nonoperatively; this may include patients who 
had sedation in the emergency department or patients 
who may have had COVID-19. these patients would not 
be captured by this audit. We included patients who 
had COVID-19 between seven days prior to and 30 days 
after their procedure; it is not currently known whether 
one week is sufficient to reduce the perioperative risk. 
It may be that we have therefore not captured compli-
cations in patients who had COVID preoperatively, but 
longer than seven days prior to surgery. however, our 
protocol is in line with other large published studies 
such as COVIDsurg.6 In the early phase of our study 
COVID-19 swab testing was not widespread and 
patients were considered to have COVID-19 based on 
symptoms – therefore it is possible that the incidence 
of COVID-19 was higher than reported for this time 
period. similarly, identification of COVID-19 status 
post- discharge was based on local/regional databases 
and data from readmissions. Patients who had asymp-
tomatic COVID-19 or who travelled to another region 
postoperatively and developed COVID-19 there may 
not have been captured. as such, the number of COVID-
19- positive patients may be an underestimate. as a 
retrospective series, some datasets were incomplete 
and there is a higher chance of errors in dates recorded. 
however, with a large cohort size of over 6,000 patients 
we feel that the data presented is representative. Our 
primary outcome measures looked at rates of COVID-19 
infection and mortality, however the numbers of cases 
of COVID-19 and mortality were small. therefore, even 
small increases in numbers could change significance 
and some of the percentages presented may provide 
a misleading picture. It is therefore important that 
absolute numbers be considered when using this data 
to plan future interventions or counselling patients. 
finally, there were significant differences in age, asa 
grade, and comorbidity profile between patients who 
died and contracted COVID-19 versus those who did 
not. these factors are to be expected, but to mitigate 
these we performed propensity matching with a 1:3 
ratio. this allowed us to better compare groups, but it 
is possible that other factors played a role that we did 
not capture in this audit.
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In conclusion, the national audit in foot and ankle 
surgery across the uk before, during, and after the 
uk national lockdown showed that the percentage of 
patients receiving foot and ankle surgery who had a 
positive diagnosis for COVID-19 in the perioperative 
period was 0.52%.the 30- day mortality rate in our 
audit was found to be 0.41%, decreasing to 0.27% if 
COVID-19- positive patients were excluded. In COVID-
19- positive patients, there was a 25.71% chance of 
mortality. Patients and treating medical personnel need 
to be aware of the risks to enable informed decisions.
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